OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment
Juwon Yang, Hyunsu Bae
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 9, pp. 1996-2004
Open Access | Times Cited: 25
Juwon Yang, Hyunsu Bae
Experimental & Molecular Medicine (2023) Vol. 55, Iss. 9, pp. 1996-2004
Open Access | Times Cited: 25
Showing 25 citing articles:
Nanomaterials for detection of biomolecules and delivering therapeutic agents in theragnosis: A review
Gokul Paramasivam, Anandhavelu Sanmugam, Vishnu Vardhan Palem, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127904-127904
Closed Access | Times Cited: 22
Gokul Paramasivam, Anandhavelu Sanmugam, Vishnu Vardhan Palem, et al.
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127904-127904
Closed Access | Times Cited: 22
Regulatory T cells in immune checkpoint blockade antitumor therapy
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
An Zhang, Tao Fan, Yixiao Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
Single Cell Inference of Cancer Drug Response Using Pathway‐Based Transformer Network
Yinghao Yao, Yuandong Xu, Yaru Zhang, et al.
Small Methods (2025)
Open Access | Times Cited: 1
Yinghao Yao, Yuandong Xu, Yaru Zhang, et al.
Small Methods (2025)
Open Access | Times Cited: 1
Exosome-mediated communication between gastric cancer cells and macrophages: implications for tumor microenvironment
Yue Qiu, Guimei Lu, Na Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Yue Qiu, Guimei Lu, Na Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment
Jacob Gadwa, Justin Yu, Miles Piper, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010405-e010405
Open Access
Jacob Gadwa, Justin Yu, Miles Piper, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010405-e010405
Open Access
Cell-mediated barriers in cancer immunosurveillance
Jafar Rezaie, Leila Chodari, Shadi Mohammadpour-Asl, et al.
Life Sciences (2024) Vol. 342, pp. 122528-122528
Closed Access | Times Cited: 4
Jafar Rezaie, Leila Chodari, Shadi Mohammadpour-Asl, et al.
Life Sciences (2024) Vol. 342, pp. 122528-122528
Closed Access | Times Cited: 4
Targeted therapy for multiple myeloma: an overview on CD138-based strategies
Federico Riccardi, Carmela Tangredi, Michele Dal Bo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Federico Riccardi, Carmela Tangredi, Michele Dal Bo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Immune Modulation and Immunotherapy in Solid Tumors: Mechanisms of Resistance and Potential Therapeutic Strategies
Suman Giri, Gopal Lamichhane, Jitendra Pandey, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2923-2923
Open Access
Suman Giri, Gopal Lamichhane, Jitendra Pandey, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2923-2923
Open Access
Many Faces of Regulatory T Cells: Heterogeneity or Plasticity?
V. G. Blinova, Dmitry D. Zhdanov
Cells (2024) Vol. 13, Iss. 11, pp. 959-959
Open Access | Times Cited: 3
V. G. Blinova, Dmitry D. Zhdanov
Cells (2024) Vol. 13, Iss. 11, pp. 959-959
Open Access | Times Cited: 3
Recent advances in understanding the immune microenvironment in ovarian cancer
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Jinxin Chen, Lu Yang, Yiming Ma, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Expanding horizons in cancer therapy by immunoconjugates targeting tumor microenvironments
Amir Fattahi, Mahboobeh Jafari, Ghazal Farahavar, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104437-104437
Closed Access | Times Cited: 3
Amir Fattahi, Mahboobeh Jafari, Ghazal Farahavar, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104437-104437
Closed Access | Times Cited: 3
Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis
Zezhong Yang, Yunzhong Jiang, Lu Wang, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Zezhong Yang, Yunzhong Jiang, Lu Wang, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Mechanisms of myeloid-derived suppressor cell-mediated immunosuppression in colorectal cancer and related therapies
Shu-Chang Nie, Yanhua Jing, Lu Lu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 5, pp. 1690-1704
Open Access | Times Cited: 2
Shu-Chang Nie, Yanhua Jing, Lu Lu, et al.
World Journal of Gastrointestinal Oncology (2024) Vol. 16, Iss. 5, pp. 1690-1704
Open Access | Times Cited: 2
Deciphering Regulatory T-Cell Dynamics in Cancer Immunotherapy: Mechanisms, Implications, and Therapeutic Innovations
Sankha Bhattacharya, Gaurav Paraskar, Megha Jha, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2215-2236
Closed Access | Times Cited: 2
Sankha Bhattacharya, Gaurav Paraskar, Megha Jha, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2215-2236
Closed Access | Times Cited: 2
Oncolytic virus and CAR-T cell therapy in solid tumors
Eleonora Ponterio, Tobias L. Haas, Ruggero De Maria
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Eleonora Ponterio, Tobias L. Haas, Ruggero De Maria
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Nanomaterials and methods for cancer therapy: 2D materials, biomolecules, and molecular dynamics simulations
Welela Meka Kedir, Lunna Li, Yaw Sing Tan, et al.
Journal of Materials Chemistry B (2024)
Closed Access | Times Cited: 1
Welela Meka Kedir, Lunna Li, Yaw Sing Tan, et al.
Journal of Materials Chemistry B (2024)
Closed Access | Times Cited: 1
Immunosuppressive microenvironment in acute myeloid leukemia: overview, therapeutic targets and corresponding strategies
Chenyu Zha, Xinyu Yang, Jun Yang, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 1
Chenyu Zha, Xinyu Yang, Jun Yang, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 1
Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective
Mehdi Bakhtiyaridovvombaygi, Somayeh Yazdanparast, Setare Kheyrandish, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Mehdi Bakhtiyaridovvombaygi, Somayeh Yazdanparast, Setare Kheyrandish, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Nanomedicine-Based Cancer Immunotherapy
Syed Hammad Ali, Mohammad Azhar Aziz
Interdisciplinary cancer research (2024)
Closed Access
Syed Hammad Ali, Mohammad Azhar Aziz
Interdisciplinary cancer research (2024)
Closed Access
A Bioinformatics Investigation of Hub Genes Involved in Treg Migration and Its Synergistic Effects, Using Immune Checkpoint Inhibitors for Immunotherapies
Nari Kim, S. Na, Junhee Pyo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9341-9341
Open Access
Nari Kim, S. Na, Junhee Pyo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9341-9341
Open Access
Divergent response to radio-immunotherapy is defined by intrinsic features of the tumor microenvironment
Jacob Gadwa, Justin Yu, Miles Piper, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Jacob Gadwa, Justin Yu, Miles Piper, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Integrating spatial profiles and cancer genomics to identify immune-infiltrated mismatch repair proficient colorectal cancers
Jeremiah A. Wala, Ino de Bruijn, Shannon Coy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Jeremiah A. Wala, Ino de Bruijn, Shannon Coy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Inhibition of UBE2N in regulatory T-cells boosts immunity against cancer
Wanying Miao, Vaibhav Jain, Min Han, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Wanying Miao, Vaibhav Jain, Min Han, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Could intratumoural microbiota be key to unlocking treatment responses in hepatocellular carcinoma?
Kin Lam Yu, Sj Shen
European Journal of Cancer (2024) Vol. 216, pp. 115195-115195
Open Access
Kin Lam Yu, Sj Shen
European Journal of Cancer (2024) Vol. 216, pp. 115195-115195
Open Access
